These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6800954)

  • 1. Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults.
    Griffiss JM; Brandt BL; Altieri PL; Pier GB; Berman SL
    Infect Immun; 1981 Dec; 34(3):725-32. PubMed ID: 6800954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of a group 29E meningococcal capsular polysaccharide vaccine in adults.
    Griffiss JM; Brandt BL; Altieri PL; Pier GB; Berman SL
    Infect Immun; 1983 Jan; 39(1):247-52. PubMed ID: 6401693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immune response to various doses of group Y and W135 meningococcal polysaccharide vaccines.
    Griffiss JM; Brandt BL; Broud DD
    Infect Immun; 1982 Jul; 37(1):205-8. PubMed ID: 6809627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
    El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
    Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antigen coating conditions on enzyme-linked immunosorbent assay for detection of immunoglobulin G antibody to Neisseria meningitidis serogroup Y and W135 capsular polysaccharide antigens in serum.
    Giardina PC; Evans RE; Sikkema DJ; Madore D; Hildreth SW
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1136-40. PubMed ID: 14607879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity and immunogenicity of bivalent (AC) and tetravalent (ACW135Y) meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive group C polysaccharide.
    Vodopija I; Baklaic Z; Hauser P; Roelants P; André FE; Safary A
    Infect Immun; 1983 Nov; 42(2):599-604. PubMed ID: 6417019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda.
    Guerin PJ; Naess LM; Fogg C; Rosenqvist E; Pinoges L; Bajunirwe F; Nabasumba C; Borrow R; Frøholm LO; Ghabri S; Batwala V; Twesigye R; Aaberge IS; Røttingen JA; Piola P; Caugant DA
    PLoS Negl Trop Dis; 2008; 2(12):e342. PubMed ID: 19048025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.
    Granoff DM; Gupta RK; Belshe RB; Anderson EL
    J Infect Dis; 1998 Sep; 178(3):870-4. PubMed ID: 9728562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.
    Blanchard-Rohner G; Snape MD; Kelly DF; O'Connor D; John T; Kibwana E; Parks H; Ford K; Dull PM; Pollard AJ
    Pediatr Infect Dis J; 2013 Jul; 32(7):768-76. PubMed ID: 23538521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.
    Anderson EL; Bowers T; Mink CM; Kennedy DJ; Belshe RB; Harakeh H; Pais L; Holder P; Carlone GM
    Infect Immun; 1994 Aug; 62(8):3391-5. PubMed ID: 8039909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.
    Chandramohan D; Hodgson A; Coleman P; Baiden R; Asante K; Awine E; Owusu-Agyei S; Boutriau D; Nelson CB; Greenwood B
    Vaccine; 2007 Sep; 25 Suppl 1():A83-91. PubMed ID: 17521782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.
    Al-Mazrou Y; Khalil M; Borrow R; Balmer P; Bramwell J; Lal G; Andrews N; Al-Jeffri M
    Infect Immun; 2005 May; 73(5):2932-9. PubMed ID: 15845499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.
    Zollinger WD; Moran EE; Devi SJ; Frasch CE
    Infect Immun; 1997 Mar; 65(3):1053-60. PubMed ID: 9038315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection.
    Rosenqvist E; Harthug S; Frøholm LO; Høiby EA; Bøvre K; Zollinger WD
    J Clin Microbiol; 1988 Aug; 26(8):1543-8. PubMed ID: 3139705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elaboration of both the group W135 and group Y capsular polysccharides by a single strain of Neisseria meningitidis.
    Brandt BL; Pier GB; Goroff DK; Altieri PL; Griffiss JM
    J Gen Microbiol; 1980 May; 118(1):39-43. PubMed ID: 6775049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
    Skevakis L; Frasch CE; Zahradnik JM; Dolin R
    J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group C Neisseria meningitidis variant polysaccharide vaccines in children.
    Steinhoff MC; Lewin EB; Gotschlich EC; Robbins JB
    Infect Immun; 1981 Oct; 34(1):144-6. PubMed ID: 6795122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity.
    Martinez J; Pilishvili T; Barnard S; Caba J; Spear W; Romero-Steiner S; Carlone GM
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):485-8. PubMed ID: 11874898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine.
    Katial RK; Brandt BL; Moran EE; Marks S; Agnello V; Zollinger WD
    Infect Immun; 2002 Feb; 70(2):702-7. PubMed ID: 11796602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.